复星医药(600196.SH)复宏汉霖向联交所呈交经更新的上市申请(A1表格)
格隆汇7月5日丨复星医药(600196.SH)公布,2018年11月27日,公司2018年第一次临时股东大会审议批准分拆控股子公司上海复宏汉霖生物技术股份有限公司(“复宏汉霖”)及其首次公开发行境外上市外资股(H股)并于香港联交所主板上市等相关事项;2018年12月13日,复宏汉霖已通过其联席保荐人向香港联交所呈交上市申请(A1表格),以申请复宏汉霖H股股份于香港联交所主板上市及获准买卖。
公司获通知,于2019年7月5日,复宏汉霖通过其联席保荐人向香港联交所呈交经更新的上市申请(A1表格)。
复宏汉霖招股章程的部分资料被遮盖的经更新的申请版本预计自2019年7月5日起可于香港联交所网站查阅及下载。申请版本载有(其中包括)关于复宏汉霖的若干业务及财务资料。
复宏汉霖H股股份的建议发售规模将不超过经扩大复宏汉霖总股本的15%,另亦建议承销商将获授不超过初步将予发售的复宏汉霖H股股份数目的15%的超额配股权。建议分拆及上市后,复宏汉霖将继续为公司的控股子公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.